Browsing by Author Skarlos, D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 7 to 26 of 66 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group StudyBriasoulis, E.; Kalofonos, H.; Bafaloukos, D.; Samantas, E.; Fountzilas, G.; Xiros, N.; Skarlos, D.; Christodoulou, C.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer TrialsKosmidis, P. A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D.24-Nov-2015-
Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective]Tsavaris, N.; Primikirios, N.; Mylonakis, N.; Varouchakis, G.; Dosios, T.; Pavlidis, N.; Skarlos, D.; Tasopoulos, T.; Dritsas, J.; Kosmidis, P.24-Nov-2015-
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupPectasides, D.; Samantas, E.; Fountzilas, G.; Briasoulis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.; Kalofonos, H. P.; Economopoulos, T.; Syrigos, K.24-Nov-2015-
Combination chemotherapy with cisplatin-vinblastine in malignant mesotheliomaTsavaris, N.; Mylonakis, N.; Karvounis, N.; Bacoyiannis, C.; Briasoulis, E.; Skarlos, D.; Pavlidis, N.; Stamatelos, G.; Kosmidis, P.24-Nov-2015-
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyKosmidis, P.; Fountzilas, G.; Baka, S.; Samantas, E.; Dimopoulos, A. M.; Gogas, H.; Skarlos, D.; Papacostas, P.; Boukovinas, J.; Bakogiannis, C.; Pantelakos, P.; Athanasiou, H.; Misailidou, D.; Tsekeris, P.; Pavlidis, N.24-Nov-2015-
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology GroupKosmidis, P.; Mylonakis, N.; Dimopoulos, A.; Pavlidis, N.; Fountzilas, G.; Samantas, E.; Dimitriadis, K.; Kalophonos, C.; Tsavdaridis, D.; Skarlos, D.24-Nov-2015-
Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II StudyBriasoulis, E.; Tsavaris, N.; Fountzilas, G.; Athanasiadis, A.; Kosmidis, P.; Bafaloukos, D.; Skarlos, D.; Samantas, E.; Pavlidis, N.24-Nov-2015-
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group StudyFountzilas, G.; Polichronis, A.; Katsohis, K.; Gennatas, K.; Toussis, D.; Skarlos, D.; Kosmidis, P.; Vassilaros, S.; Semoglou, C.; Giannakakis, T.; Fahantidis, E.; Klouvas, G.; Tsavaris, N.; Konstantaras, C.; Makrantonakis, P.; Kolotas, C.; Zamboglou, N.; Tsiliakos, S.; Hainoglou, D.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group StudyNicolaides, C.; Fountzilas, G.; Zoumbos, N.; Skarlos, D.; Kosmidis, P.; Pectasides, D.; Karabelis, A.; Giannakakis, T.; Symeonidis, A.; Papadopoulos, A.; Antoniou, F.; Pavlidis, N.24-Nov-2015-
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility studyFountzilas, G.; Nicolaides, C.; Aravantinos, G.; Skarlos, D.; Kosmidis, P.; Papakostas, P.; Stathopoulos, G. P.; Kontostolis, E.; Bafaloukos, D.; Pavlidis, N.24-Nov-2015-
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerFountzilas, G.; Papadimitriou, C.; Aravantinos, G.; Nicolaides, C.; Stathopoulos, G.; Bafaloukos, D.; Kalofonos, H.; Ekonomopoulos, T.; Skarlos, D.; Pavlidis, N.; Dimopoulos, A. M.24-Nov-2015-
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Papadimitriou, C.; Dafni, U.; Bafaloukos, D.; Skarlos, D.; Moulopoulos, L. A.; Razis, E.; Kalofonos, H. P.; Aravantinos, G.; Briassoulis, E.; Papakostas, P.; Abela, K.; Gogas, E.; Kosmidis, P.; Pavlidis, N.; Dimopoulos, M. A.24-Nov-2015-
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experiencePectasides, D.; Fountzilas, G.; Aravantinos, G.; Bamias, A.; Kalofonos, H. P.; Skarlos, D.; Briasoulis, E.; Konstantara, A.; Economopoulos, T.; Dimopoulos, M. A.24-Nov-2015-
Evaluation of 6 Tumor-Markers in Patients with Carcinoma of Unknown PrimaryPavlidis, N.; Kalefezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; Fountzilas, G.24-Nov-2015-
Evaluation of six tumor markers in patients with carcinoma of unknown primaryPavlidis, N.; Kalef-Ezra, J.; Briassoulis, E.; Skarlos, D.; Kosmidis, P.; Saferiadis, K.; Bairaktari, E.; Bafaloukos, D.; Maravegias, A.; Theoharis, D.; et al.,24-Nov-2015-
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyKostopoulos, I.; Arapantoni-Dadioti, P.; Gogas, H.; Papadopoulos, S.; Malamou-Mitsi, V.; Scopa, C. D.; Markaki, S.; Karagianni, E.; Kyriakou, V.; Margariti, A.; Kyrkou, E.; Pavlakis, K.; Zaramboukas, T.; Skordalaki, A.; Bourli, A.; Markopoulos, C.; Pectasides, D.; Dimopoulos, M. A.; Skarlos, D.; Fountzilas, G.24-Nov-2015-
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II studyPectasides, D.; Dimopoulos, M. A.; Aravantinos, G.; Kalophonos, H. P.; Papacostas, P.; Briasoulis, E.; Cogas, E.; Papadimitriou, C.; Skarlos, D.; Kosmidis, P.; Fountzilas, G.24-Nov-2015-
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Dimopoulos, A. M.; Papadimitriou, C.; Kalogera-Fountzila, A.; Aravantinos, G.; Bafaloukos, D.; Athanassiades, A.; Nicolaides, C.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Zisiadis, A.; Dafni, U.; Konstantaras, C.; Hatzitheoharis, G.; Papavramidis, S.; Bousoulegas, A.; Basdanis, G.; Giannoulis, E.; Dokmetzioglou, J.; Katsohis, C.; Nenopoulou, E.; Karvounis, N.; Briassoulis, E.; Aravantinos, G.; Kosmidis, P.; Skarlos, D.; Pavlidis, N.24-Nov-2015-